Eveready Inds. Q2 FY27 Earnings Call — Analysis (NSE: EVEREADY)
Eveready reported its 8th consecutive quarter of revenue growth at 10.7% YoY to ₹428.2 Cr, driven by alkaline batteries and rechargeable flashlights, while commercial production commenced at its new Jammu facility.
Result quality: stable — Results context unavailable. Management sentiment: optimistic.
The take
Q2FY27 Revenue from Operations ₹428.2 Cr ( +10.7% YoY ) . New guidance — FY29 net debt status debt-free . New story: Premiumization & Alkaline Shift .
Results
Revenue grew 10.7% YoY to ₹428.2 Cr; EBITDA rose 8.9% YoY to ₹53.8 Cr with a 12.6% margin (-20bps YoY); PAT stood at ₹31.9 Cr.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue from Operations | ₹428.2 Cr | +10.7% | yoy · Q2FY27 |
| EBITDA | ₹53.8 Cr | +8.9% | yoy · Q2FY27 |
| EBITDA Margin | 12.6% | -20bps | yoy · Q2FY27 |
| Profit After Tax | ₹31.9 Cr | yoy · Q2FY27 · vs loss of ₹7.9 Cr in Q2FY26 | |
| Net Debt | ₹153 Cr | point_in_time · Q2FY27 · Sep-26 |
Guidance
Management aims to become a debt-free company within 1.5 to 2 years, supported by land sale cash inflows and absence of major capex.
What management committed to
- In the next 2 years, we should be definitely a debt-free company, unless any decisions taken otherwise. — debt-free, FY29
- the mosquito side between [mosquito] rackets and liquid vaporizers could reach and cross more than INR100 crores by the end of FY29 — INR 100 crores+, FY29
- definitely it is going to fully cover [margin pressure] in a Quarter 4 — full recovery, Q4 FY27
- We are expecting somewhere between 3% to 4% [market share in liquid vaporizers] to be coming through — 3% to 4%, FY28/FY29
- this quarter largely will be from the Jammu plant [for alkaline battery billing] — largely from Jammu, Q3 FY27
- scout for business and apply for various kinds of tenders [for global white-label alkaline]...journey is over the next 1 or 2 years — scouting and applying, FY28/FY29
Key themes
Jammu localisation and portfolio premiumisation
How the narrative shifted
- Macro Cost Headwinds: Set up as the dominant challenge, juxtaposed with the company's ability to navigate it through hedging and efficiency.
- Premiumization & Alkaline Shift: Positioned as the core driver of profitable growth and a buffer against value erosion in the mature zinc battery market.
- Jammu Plant Localization: Framed as a key strategic asset for margin improvement and self-reliance, with effects materializing over the coming quarters.
- New Product Diversification: Presented as the engine for future growth beyond the core battery business, with ambitious revenue targets (INR 100 cr mosquito portfolio by FY29).
- Deleveraging & Balance Sheet Strength: Highlighted as a major positive development, reinforcing financial stability and future investment capacity.
- E-commerce & Channel Evolution: Presented as a key growth vector, though airtime is limited relative to cost and product themes.
- Lighting Business Restructuring: Managed defensively. Emphasis on stabilization (breakeven) rather than growth, acknowledging the challenging competitive environment.
- Regulatory Ambiguity (EPR): Framed as an external factor beyond control, with proactive engagement to minimize potential financial impact.
Operational commentary
- Jammu manufacturing plant commenced commercial production in May with billing started in September 2026; indigenously produced alkaline batteries expected to improve margins by 6-7% over imported ones.
- Alkaline battery segment delivered 30% YoY volume growth in Q2FY27, supporting dry cell market share gains.
- Rechargeable flashlights grew 33.2% YoY, offsetting subdued demand in conventional battery-operated torches.
- Emergency LED lighting portfolio expanded with 26% YoY growth; launched Xtrabright emergency bulb and SHOR animal-deterrent rechargeable farm torch.
- Entered anti-mosquito segment with portable rechargeable liquid vaporiser and mosquito racquets, targeting over ₹100 Cr revenue from the category by FY29.
- E-commerce and quick commerce distribution channels grew over 50% YoY in Q2FY27.
Analyst Q&A
Q. What led to the 20 bps EBITDA margin compression and what is the outlook?
Compression was driven by elevated raw material costs (zinc up 36% YoY) and channel/product mix; calibrated price hikes will help recover margins largely in Q3 and fully by Q4.
Q. What is the status of the capital subsidy on the Jammu facility?
Awaiting NCSS registration approval due to fund allocations at DPIIT/Jammu industry department; if approved, eligible annual subsidy could be ₹20-25 Cr over a 10-year period.
Q. What is the potential impact of Extended Producer Responsibility (EPR) regulations on dry cell batteries?
Discussions ongoing with Ministry of Environment and Pollution Control Board over pricing and compliance ambiguities; resolution expected in Q3FY27 following compliance extension to November 30.
Research and educational content only. Not investment advice.